Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-029775
Filing Date
2019-05-14
Accepted
2019-05-14 18:38:57
Documents
1
Period of Report
2019-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4795
  Complete submission text file 0001209191-19-029775.txt   6304
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Issuer) CIK: 0000791908 (see all company filings)

EIN.: 522154066 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XOMA LTD 2910 SEVENTH ST. BERKELEY CA 94710
Business Address
VAN NESS W DENMAN (Reporting) CIK: 0001221676 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-14710 | Film No.: 19824376